Robert Schmidt

Robert R. Schmidt is a Managing Director - Partner and the Global Co-Head of Healthcare at Carlyle. He is based in New York.

Since joining Carlyle in 2011, Mr. Schmidt has been involved in a number of the firm’s investments globally, including Beats Electronics, Included Health (formerly Grand Rounds), Medline, MedRisk, One Medical, QuidelOrtho (formerly Ortho Clinical Diagnostics), Resonetics, Sedgwick, Unchained Labs, and Vantive. He is currently a member of the board of directors of Included Health, Medline, MedRisk, Resonetics, Unchained Labs, and Vantive.

Prior to joining Carlyle, Mr. Schmidt worked at Welsh, Carson, Anderson & Stowe, a private equity firm focused on healthcare and technology investments, and Merrill Lynch Global Private Equity, where he focused on buyouts in North America.

Mr. Schmidt earned his M.B.A. from Harvard Business School and a B.S. in economics from The Wharton School at the University of Pennsylvania. He is currently a member of the External Advisory Board at the Leonard Davis Institute of Health Economics at the University of Pennsylvania.